Cognitive Behavioral Therapy for Melanoma
What You Need to Know Before You Apply
What is the purpose of this trial?
This clinical trial studies how people feel and live during the first two years after being treated for melanoma and whether cognitive behavioral therapy for cancer distress (CBT-C) works to improve quality of life in patients with stage III-IV melanoma. The melanoma survivorship population is rapidly growing, given the increasing survival rates due to treatment advancements. An urgent need to better define and optimize comprehensive quality of life inclusive of mental health (QOL-MH) has been identified. Cognitive behavioral therapy is a type of psychotherapy that helps patients change their behavior by changing the way they think and feel about certain things. CBT-C is a new type of care that helps patients cope with cancer-related stress, which can include problems like trouble sleeping, trouble focusing, or changes in social life and daily activities. Gathering information on how melanoma patients feel and live during the first two years after treatment may help promote improved care and continued scientific advancements in the understanding of melanoma specific QOL-MH and survivorship as a whole, and may also help determine whether CBT-C improves qualify of life in patients with stage III-IV melanoma.
Who Is on the Research Team?
Shawna L. Ehlers, PhD, LP
Principal Investigator
Mayo Clinic
Are You a Good Fit for This Trial?
This trial is for adults over 18 with stage III-IV melanoma diagnosed within the last two months. Participants must be able to read English well enough to understand surveys and consent forms.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants attend CBT-C sessions once a week for 6 weeks or receive SOC for 6 weeks
Quality of Life Assessment
Participants complete QOL-MH questionnaires at baseline and 3, 6, 9, 12, 18, and 24 months post-stage III-IV diagnosis
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Cognitive Behavior Therapy
Trial Overview
The study looks at how quality of life, including mental health, is affected after melanoma treatment. It tests if cognitive behavioral therapy specifically designed for cancer-related stress can improve life for those recently treated for advanced melanoma.
How Is the Trial Designed?
3
Treatment groups
Experimental Treatment
Active Control
Patients attend CBT-C sessions once a week for 6 weeks in the absence of unacceptable toxicity.
Patients complete QOL-MH questionnaires at baseline and 3, 6, 9, 12, 18, and 24-months post-stage III-IV diagnosis. Patients living in Minnesota, Iowa, or Wisconsin may also optionally participate in aim 2.
Patients receive SOC for 6 weeks in the absence of unacceptable toxicity.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Mayo Clinic
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.